Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Unknown 10Recruiting 8Not yet recruiting 3Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Head and Neck Neoplasms 121Lung Neoplasms 119Glioblastoma 118Carcinoma, Non-Small-Cell Lung 118Breast Neoplasms 105Lymphoma 102Squamous Cell Carcinoma of Head and Neck 90Central Nervous System Neoplasms 83Prostatic Neoplasms 80Leukemia 77Pancreatic Neoplasms 67Gliosarcoma 66Rectal Neoplasms 63Precursor Cell Lymphoblastic Leukemia-Lymphoma 63Esophageal Neoplasms 63Brain Neoplasms 59Lymphoma, Large B-Cell, Diffuse 56Lymphoma, Follicular 55Lymphoma, Non-Hodgkin 49Hodgkin Disease 48Burkitt Lymphoma 46Sarcoma 43Lymphoma, Large-Cell, Immunoblastic 42Leukemia, Lymphocytic, Chronic, B-Cell 42Myelodysplastic Syndromes 37Lymphoma, Mantle-Cell 36Glioma 36Neoplasms 34Astrocytoma 34Lymphoma, B-Cell, Marginal Zone 33

Interventions

Cisplatin 22Radiotherapy, Intensity-Modulated 12Fluorouracil 9Gemcitabine 7Docetaxel 7Cetuximab 5Capecitabine 5pembrolizumab 4nimotuzumab 3nedaplatin 3Radiotherapy 3Radiation 3Carboplatin 3toripalimab 2spartalizumab 2camrelizumab 2anlotinib 2Quality of Life 2Protons 2Paclitaxel 2Nivolumab 2Dexamethasone 2Chemoradiotherapy 2tislelizumab 1raltitrexed 1penpulimab 1icotinib 1fosaprepitant 1famitinib 1endostar protein 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Nasopharyngeal Carcinoma × Radiotherapy × Clear all
NCT03267498 2026-01-12

Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)

University of California, San Francisco

Phase 2 Completed
40 enrolled 14 charts
Head & Neck

Nasopharyngeal Carcinoma

NCT05292027 2024-12-31

Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

Sichuan Cancer Hospital and Research Institute

Phase NA Completed
84 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT00535795 2019-03-01

Phase III: Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA

King Faisal Specialist Hospital & Research Center

Phase 3 Completed
200 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡